IndraLab

Statements



reach
"Likewise, amodiaquine, benzbromarone, disulfiram and bicalutamide decreased cell viability only in BSO treated HepG2 cells."

reach
"Interestingly, there were cell-type dependent effects of BSO treatment on cell viability as amodiaquine, benzbromarone, bicalutamide, and disulfiram significantly decreased cell viability under BSO tr[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"